These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32992328)

  • 1. Epitope-Specific Antibody Responses to a Plasmodium falciparum Subunit Vaccine Target in a Malaria-Endemic Population.
    Friedman-Klabanoff DJ; Travassos MA; Ifeonu OO; Agrawal S; Ouattara A; Pike A; Bailey JA; Adams M; Coulibaly D; Lyke KE; Laurens MB; Takala-Harrison S; Kouriba B; Kone AK; Doumbo OK; Patel JJ; Thera MA; Felgner PL; Tan JC; Plowe CV; Berry AA
    J Infect Dis; 2021 Jun; 223(11):1943-1947. PubMed ID: 32992328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.
    Carapau D; Mitchell R; Nacer A; Shaw A; Othoro C; Frevert U; Nardin E
    Infect Immun; 2013 Dec; 81(12):4350-62. PubMed ID: 24042110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
    Gregson AL; Oliveira G; Othoro C; Calvo-Calle JM; Thorton GB; Nardin E; Edelman R
    PLoS One; 2008 Feb; 3(2):e1556. PubMed ID: 18253503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
    Espinosa DA; Gutierrez GM; Rojas-López M; Noe AR; Shi L; Tse SW; Sinnis P; Zavala F
    J Infect Dis; 2015 Oct; 212(7):1111-9. PubMed ID: 25762791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
    Murugan R; Scally SW; Costa G; Mustafa G; Thai E; Decker T; Bosch A; Prieto K; Levashina EA; Julien JP; Wardemann H
    Nat Med; 2020 Jul; 26(7):1135-1145. PubMed ID: 32451496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of
    Kurtovic L; Wetzel D; Reiling L; Drew DR; Palmer C; Kouskousis B; Hanssen E; Wines BD; Hogarth PM; Suckow M; Jenzelewski V; Piontek M; Chan JA; Beeson JG
    Front Immunol; 2021; 12():641421. PubMed ID: 33815393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
    Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
    PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
    Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.
    Virnik K; Zhou W; Medvedev A; Walsh G; Perry-Anderson J; Majam V; Felber BK; Kumar S; Berkower I
    Biochem Biophys Res Commun; 2021 Nov; 577():58-63. PubMed ID: 34507066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity.
    Thai E; Costa G; Weyrich A; Murugan R; Oyen D; Flores-Garcia Y; Prieto K; Bosch A; Valleriani A; Wu NC; Pholcharee T; Scally SW; Wilson IA; Wardemann H; Julien JP; Levashina EA
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32790871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM; Oliveira GA; Nardin EH
    J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
    Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
    Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
    PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC; Bitzer AA; Giri A; Luo K; Sankhala RS; Choe M; Zou X; Dennison SM; Li Y; Washington W; Ngauy V; Tomaras GD; Joyce MG; Batchelor AH; Dutta S
    Sci Rep; 2021 Mar; 11(1):5318. PubMed ID: 33674699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
    Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
    Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
    Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.